Results 271 to 280 of about 81,856 (291)

Commentary on ‘Treatment-resistant major depressive disorder and assisted dying’

Journal of Medical Ethics, 2015
Schuklenk and van de Vathorst (henceforth “the authors”) make the following starting assumption, which I will accept: that it is ethically permissible for doctors to assist suicide and it is permissible for those competent patients with terminal somatic diseases (such as inoperable stage IV cancer) or non-terminal but untreatable debilitating diseases (
openaire   +2 more sources

Adjunctive Quetiapine for Treatment-Resistant Adolescent Major Depressive Disorder: ACase Series

Journal of Child and Adolescent Psychopharmacology, 2005
Major depressive disorder (MDD) is a leading cause of disability and mortality in adolescents. Empirical evidence suggests that many adolescents with MDD do not respond or respond only partially to commonly used interventions (antidepressants, psychotherapy, or a combination of antidepressants and psychotherapy).
Sanjeev, Pathak, Erin S, Johns, Robert A, Kowatch   +2 more
openaire   +2 more sources

Emerging Treatment Options in Treatment-Resistant Depression and Anxiety Disorders

CNS Spectrums, 2002
ABSTRACTManagement strategies for treatment-resistant depression and anxiety disorders have evolved over the last decade. Our understanding of the factors that impair recovery from an episode of major depression has increased, leading to the development of more precise diagnostic methodology that highlight the presence of comorbid conditions.
Waguih William IsHak, Mark H. Rapaport, Jennifer G. Gotto   +2 more
openaire   +1 more source

[Major depressive disorder and treatment-resistant depression: an epidemiological analysis in Argentina of the Study of Treatment-Resistant Depression in Latin America].

Vertex (Buenos Aires, Argentina), 2022
Treatment-Resistant Depression (TRD) prevalence varies considerable between regions and epidemiology of TRD in Argentina is lacking. Based on the Treatment-Resistant Depression in America Latina (TRAL) study, epidemiology and burden of TRD in MDD patients from Argentina is reported in this paper.
Gerardo, García Bonetto, Ricardo Marcelo, Corral, Christian, Lupo, Manuel, Vilapriño Duprat, Hernán, Alessandria, Gabriela, Kanevsky, Patricia, Cabrera   +6 more
openaire   +1 more source

Choosing death in depression: a commentary on ‘Treatment-resistant major depressive disorder and assisted dying’

Journal of Medical Ethics, 2015
Schuklenk and van de Vathorst's paper is a very welcome addition to the literature on the assisted dying debate and will be of great interest to clinicians working in the field of mental health.1 Many psychiatrists will have had patients who have asked them to allow them to die, to desist in their efforts to prevent their suicide, and one of us has had
Matthew R, Broome, Angharad, de Cates
openaire   +2 more sources

Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder

Psychedelic Medicine
Background: Bipolar II disorder (BD-II) is often associated with chronic and treatment resistant major depressive episodes. Psilocybin has shown promise for its rapid-acting antidepressant effects, though its impact on bipolar depression remains unexplored.
Shakila Meshkat, Erica Kaczmarek, Zoe Doyle, Ryan M. Brudner, Fabiano A. Gomes, Marc G. Blainey, Geneva Weiglein, Roger S. McIntyre, Rodrigo B. Mansur, Joshua D. Rosenblat   +9 more
openaire   +2 more sources

Genomic Studies of Treatment Resistance in Major Depressive Disorder

2016
Treatment-resistant depression describes the subset of individuals with major depressive disorder who do not reach symptomatic remission despite multiple adequate treatment trials. While treatment resistance has a substantial impact on functioning, quality of life, and healthcare costs, little is known about the underlying neurobiology.
openaire   +1 more source

Treatment-Resistant Depression or Misdiagnosed Anxiety Disorder?

Journal of Nervous & Mental Disease, 2016
Edward K, Silberman, Kenneth J, Weiss
openaire   +2 more sources

Topiramate in treatment‐resistant depression and binge‐eating disorder

Bipolar Disorders, 2002
Pedro Antônio, Schmidt do Prado-Lima, Josué, Bacaltchuck   +1 more
openaire   +2 more sources

Treatment-resistant depression: a possible 'inflammatory subtype' of depressive disorder

Journal of Affective Disorders, 2019
Dr Rebecca Strawbridge, Professor Allan H Young, Professor Anthony J Cleare   +2 more
openaire   +1 more source